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ABSTRACT 
 
In this thesis, we examine epidemiological models of two different retroviruses, which infect the 
human body.  The two viruses under study are HIV or the human immunodefiency virus and 
HTLV-I, which is the human T lymphotropic virus type I.  A retrovirus is a virus, which injects 
its RNA into the host, rather than it’s DNA.  We will study each of the different mathematical 
models for each of the viruses separately. Then we use MATLAB-SIMULINK to analyze the 
models by studying the reproductive numbers in each case and the disease progression by 
examining the graphs. In Chapter 1, we mention basic ideas associated with HIV and HTLV-I. In 
Chapter 2 some of the basic mathematical model of epidemiology is presented.  Chapter 3 is 
devoted to a model describing the intra-host dynamics of HIV.  Here, we take into account how 
HIV infects and replicates in the CD4+ T cells.  The model studied in this thesis examines the 
difference between cells, which are susceptible to the virus, and cells, which are not susceptible.  
Through the graphs associated with this model, we are able to see how this difference affects 
disease progression.  In Chapter 4, we examine the effect of HTLV-I virus on human body.  The 
HTLV-I virus causes a chronic infection in humans and may eventually lead to other diseases.  
In particular, the development of Adult T-cell Leukemia or ATL is studied in this thesis.  The T-
cell dynamics and progression to ATL is described using a mathematical model with coupled 
differential equations. Using mathematical analysis and SIMULINK, we obtain results on 
stability, asymptotic stability and the manner of progression of the disease. In Chapter 5 and 
appendices, we mention our inference and the MATLAB-SIMULINK codes used in this thesis, 
so that a reader can verify the details of the work carried out in this thesis. 
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CHAPTER ONE - INTRODUCTION 
1.1 Introduction 
Disease has played an important part throughout the history of mankind.  Diseases have 
influenced the growth or decline of a population and have impact on the economy.  It causes 
more deaths than any other source, including war and natural disasters.  The manner in which 
diseases infect and invade a population has perplexed doctors and scientist for many years.  A 
branch of science called epidemiology was developed in order to help analyze and understand 
the spread of disease. 
Aristotle and Hippocrates of Cos started studying the transmission of diseases during 
300BC-400BC.  Later, germ theory was first studied by Jacob Henle in 1840 and was later 
developed by Robert Koch, Joseph Lister, and Louis Pasteur.  Modern mathematics was first 
used in the study of diseases in 1873 by P.D En'ko.  Sir R. A. Ross, W. H. Hamer, A.G 
Mckendrick, and W. O Kermack laid the foundation of mathematics in epidemiology between 
1900 and 1935. (See [15])  The study of epidemiology has grown tremendously since and most 
known communicable diseases have been modeled and analyzed. 
Epidemiology not only helps us to understand disease transmission, but also to know how 
to control the spread of a particular disease.  It is not a static science and is constantly changing.  
Infectious diseases are constantly evolving and changing, making them harder to control.  New 
strains, which are immune to antibiotics, are found everyday.  HIV and HTLV-I are two new 
viruses which were first discovered in the 1980’s.  These viruses have no known cure but doctors 
are working with epidemiologist, mathematicians, and scientist to find a cure and limit its 
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transmission.  We will use mathematical models to help us understand the spread of these viruses 
in the human body and the progression of these viruses to disease. 
1.2 Introduction to HIV 
In 1981 the Center for Disease Control reported on an unusual collection of homosexual 
males that had Pneumocyctis carinii pneumonia and Kaposi’s sarcoma.  These men were 
previously healthy individuals.  This was a new retroviral disease later to be named AIDS or 
Acquired Immunodeficiency Syndrome,  a disease for which there is still no cure and is the 
fourth leading cause of death worldwide.  The etiologic agent of this new epidemic is the human 
immunodeficiency virus or HIV, which will be studied in detail in this thesis.  HIV is the 
retrovirus which causes AIDS.  This virus slowly destroys the immune system over many years.  
Once the immune system is depleted, AIDS occurs. 
AIDS was first discovered in the United States but now affects the entire world and is 
considered the new “plague”.  It has killed more than 25 million people worldwide and is 
considered the most destructive epidemic in recorded history.  AIDS is now found in more than 
163 countries with the most being in Africa and the Caribbean being the second.  Sub-Saharan 
Africa is considered to be the global epicenter of the HIV epidemic. (See [5])  Ninety percent of 
the individuals infected with HIV are in developing countries and forty percent of those infected  
are females.  Individuals in the 15-24 age group are the fastest growing segment who are being 
infected with HIV. 
HIV can be transmitted in different ways.  The virus is present in bodily fluids, 
specifically blood, therefore, any activity that results in the transfer of bodily fluid can 
potentially result in the transfer of HIV.  Intimate sexual contact is one of the modes in which 
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fluid transfer occurs.  Intravenous drug use is another mode in which HIV is transmitted between 
individuals because many drug users share needles.  Two other modes which are not as common 
due to medical advances and new antiretroviral drugs are mother to child transmission and 
transmission through blood transfusion.  Mother to child transmission can occur during the 
birthing process or through breast feeding.  Although the rate of mother to child transmission has 
dropped in many developing countries, it is still very prevalent in the sub-Saharan regions of 
Africa.  Transmission due to blood transfusions are rarely seen today due to examination of the 
blood from donors for presence of HIV prior to saving them in the blood bank for patient use.  
The U.S. blood supply is very safe due to the extensive questioning of blood donors and the 
extensive testing of donated blood. 
HIV is characterized by immunosuppression, neurologic involvement and secondary 
tumors.  HIV attacks the CD4+ T-cells, which are responsible for the immune system.  The 
nature of this attack and how it occurs is modeled mathematically in Chapter Three in order to 
help us understand and predict the course of the disease.  Many graphs developed from the 
mathematical model help demonstrate the progression to AIDS.  The graphs were produced 
using Simulink and match those produced by Stilianakis and Schenzle in Fortran. 
1.3 Introduction to HTLV-I 
Human T-lymphotropic virus (HTLV-I) was the first retrovirus to be discovered.  This 
virus was discovered in Japan in 1980.  HTLV-I is a virus which lays latent for many years 
before causing other diseases to proliferate.  This virus is the predominant cause of two diseases.  
The first one is Adult T Cell leukemia/lymphoma or ATL, which is a T cell non-Hodgkin’s 
lymphoma with a leukemic phase of circulating CD4+T cells.  The progression from HTLV-I to 
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ATL is mathematically modeled and studied in Chapter 4.  The discovery of HTLV-I provided 
scientists with a clear proof of a relationship between viruses and cancer.  The second disease 
that is cause by HTLV-I is myelopathy (HAM) which is also known as tropical spastic para 
paresis (TSP).  Usually this virus does not produce disease until approximately twenty years after 
initial infection.  HTLV-I can also cause autoimmune or chronic inflammatory disorders such as 
arthropathy, Sjogren’s syndrome and facial nerve palsy.  Identification of the HTLV-I virus 
facilitated the discovery and isolation of HIV.   
HTLV-I infects ten to twenty million people world wide but only produces disease in 
approximately five percent of infected individuals.  Women are twice as likely to contract 
HTLV-I as men.  The HTLV-I infection is thought to occur in geographical clusters which are 
located in southern Japan, the Caribbean, parts of Africa, the Middle East, South America, 
Pacific Melanesian islands, and Papua New Guinea.  The virus is also found in the southeastern 
United States in certain immigrant groups. 
HTLV-I is transmitted in the same way as HIV, through bodily fluid transfer.  Unlike 
HIV, the main transmission is through breast feeding.  The HTLV-I antigen is found in the 
infected mother’s milk and is transmitted most likely through lymphocytes in the milk.  The 
prevalence of this vertical transmission through breast feeding has caused a clustering of cases in 
familial or geographically discrete groups. (See [14])  Other modes of are sexual transmission, 
infection from blood transfusion, and sharing needles among drug users.   
 Many people can be infected with HTLV-I and will never develop a disease from this 
virus.  Chapter Four will feature a mathematical model of the HTLV-I infection of CD4+ T-cells 
and the eventual progression to ATL.  The stability analysis will illustrate two different steady 
states.  One steady state when the virus will not progress to ATL, and another steady state when 
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the virus will progress to ATL.  A proposition for asymptotical stability is studied and a graph 
was produced using Simulink.  Even after rigorous analysis, this graph does not match the graph 
presented by the authors and further work may be needed in order to explore the difference. 
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CHAPTER TWO – BACKGROUND STUDY 
2.1 Introduction to mathematical models 
A mathematical model is a mathematical description of a real world system or event. (See 
[12])  Epidemiologists will use mathematical models in order to understand and predict the 
course of an infection or disease.  A well-formulated model can help an epidemiologist 
determine where resources need to be allocated and how those resources can help control or 
eradication of the disease.  In order to formulate a model for an infectious disease, an individual 
must first collect an abundance of empirical data through clinical testing.  Once this data is 
collected and analyzed, the modelers develop a model using the following steps.  Firstly, they 
note all the relevant assumptions, and then determine the relationship between the variables and 
parameters used in the model and finally, analyze any specific patterns that are found.  Deciding 
which parameters and variables will be used in the model and how much importance should be 
given depend on the characteristics of the disease under study and the intention of the model. 
(See [2])  Once the model is formulated and analyzed, it will help the scientists to draw 
inferences form a set of hypotheses in order to determine the course of the disease in an 
individual or in a population. 
Epidemiological models are usually formed using the general MSEIR model.  This model 
places individuals from a constant population into certain groups within the model and describes 
the transition rate between each group.  Each letter represents a different class or group.  M 
represents the temporary immunity that a mother can pass on to her child through the placenta.  
The S describes the susceptibles, which are the members of the population who are at risk for 
contracting the disease.  E stands for exposed and describes the individuals from the population 
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who are infected by the disease but are not infectious due to a latent period of a disease.  The I 
group is the Infectious group or the individuals from the population who have the ability to pass 
the disease to other members of the population.  R represents the group of individuals who have 
recovered from the disease, whether temporary or permanent, and also possess some type of 
immunity. 
2.2 Basic SIR Model 
The first model to consider is the basic SIR model.  It is a simple epidemic model 
developed by Kermack and McKendrick in 1927 to predict the behavior of many historical 
epidemics such as cholera, influenza, and the Great Plague.  This model is used by many 
epidemiologists because it can help predict the behavior and progress of different diseases.  This 
model is also a building block for many of the other more complicated models.  The SIR model 
considers a population that remains constant.  The population is divided into three classes: first, 
the individuals who are susceptible, S, to the disease, second, the individuals being exposed and 
infected by the disease, I, and last the individuals who will recover, R, from the infection and 
gain immunity to the disease.  This model does not consider any latent period of the disease.  
Once an individual is infected, he is automatically moved into the infectious classification.  The 
progress of the individuals from class to class can be demonstrated by 
 
   S                            I                            R 
 
Some models only consider the S and I classes.  Other models consider a fourth class, E, which 
takes in account a latent period of the disease in which the virus is present in the host but has not 
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infected the host.  When modeling a disease like AIDS, it is better to use a model which includes 
this class. 
This model makes many assumptions.  We must first assume the collection of 
individuals in each class is a differentiable function of time.  This is reasonable as long as there 
are enough people in each class.  Next, the model is deterministic.  This means that the behavior 
of the model is determined by the past behavior of diseases.  A stochastic model would be more 
effective if the model described classes with small populations.  Third, this model does not 
include a latent phase of the disease, which means that once a susceptible becomes infected, the 
individual is automatically placed into the infected class.  Fourth, the model assumes that an 
infected individual makes contact significant enough to transmit the disease at the contact rate, 
β .  If SN I S
N
Iβ β= , new cases will occur when N is the total number in the population, S is 
the number of susceptibles and I is the number of infecteds.  The fifth assumption is that the 
model has a mass action principle, which means every individual within the population has an 
equal chance to have contact with every other individual in the population.  This information 
implies that β , the contact rate, is the ratio of rate of contact to the population size.  Another 
assumption is that the recovery rate is proportional to the number of infecteds, and is represented 
by aI, where a is the removal rate.  The last assumption is that there is no entry or exit from the 
population except through death.  This occurs when the progression to disease is so quick that 
birth and death rates can be ignored.  This assumption can be changed in certain models. 
 Based on these assumptions, the classic Kermack and McKendrick model is: 
 dS SI
dt
β= −  (2.1) 
 dI SI aI
dt
β= −  (2.2) 
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 dR aI
dt
=  (2.3) 
Note that only non-negative solutions for S, I and R are of interest.  Also, remember the total 
population is constant and is embedded in the model.  If we add equations (2.1)-(2.3), we will 
get: 
 0dS dI dR
dt dt dt
+ + =  (2.4) 
Solving this differential equation will yield: 
 ( ) ( ) ( )S t I t R t N+ + =  (2.5) 
where N is the population size.  We also have the following initial conditions: 
  (2.6) 0 0(0) , (0) , (0)S S I I R= = = 0R
where  and . 0 0S > 0 0I >
 The population is constant, therefore, R can be determined if S and I are known.  For this 
reason, equation (2.3) can be dropped and the system can be reduced to only two equations.  This 
system is not possible to solve analytically but the equations can be analyzed using a qualitative 
approach.  Note that  and  if 0S ′ < 0I ′ > 0 aS β> .  Since S is decreasing, I will initially increase 
but then will decrease to zero.  The possibility of I increasing is what indicates an epidemic 
because I represents the infected individuals.  If 0
aS β< , then I will go to zero and there is no 
epidemic.  If 0
aS β> , the number of infected individuals will first increase to 
aS β= , and then 
decrease to zero.  From this, we see a threshold parameter.  The behavior of the disease will 
depend on the threshold quantity, 0S
a
β .  This number defines the reproduction number.  The 
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reproduction number, 0R , of the system is defined as the number of secondary infections 
produced by one primary infection in the population of susceptibles.  Therefore: 
 00
SR
a
β=  (2.7) 
This number measures how fast the infection will spread.  If 0 1R < , the infection will not 
continue and the disease will disappear.  If 0 1R = , the infection will remain stable in 
transmission.  If , an epidemic will occur. (See [3])  To find the trajectories in the phase 
plane, we first divide the two equations of the model and get: 
0 1R >
 ( ) 1dI S a I a
dS SI S
β
β β
−= = − +−  (2.8) 
Separation of variables and integration yields: 
 logaI S Sβ c= − + +  (2.9) 
where c is an arbitrary constant of integration.  Equation (2.9) can be defined as the following 
quantity: 
 ( , ) logaJ S I S I Sβ= + −  (2.10) 
where J(S,I)=c.  Different constants will give different trajectories and this constant can be 
obtained by knowing the initial values of and 0, ,S I S 0I .  We now have: 
 0 0 0 0 0( , ) log
aJ S I S I S cβ= + − =  (2.11) 
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If we assume a population of size K and introduce a small number of infecteds into the 
population so  and , we can determine 0S K≈ 0 0I ≈ 0 KR a
β=  from equation (2.7).  Taking the 
fact that li  and lim ( ) 0
t
I t→∞ = m ( )t S t S∞→∞ = , we can find 0 0( , ) ( ,0)J S I J S∞= .  This will yield: 
 0log log
a aK S Sβ β S∞ ∞− = −  (2.12) 
This helps to determine the reproduction number because it will give an expression for 
a
β  in 
parameters that can be determined: 
 0log SaK S
Sβ∞ ∞− =  (2.13) 
 
0log S
S
a K S
β ∞
∞
= −  (2.14) 
Note  because the initial number of susceptible will be greater than the number of 
susceptible who will become infected.  This will occur because there are some who will not 
come into contact with the disease. 
0S S∞>
2.3 Basic SIS Model 
 The SIS model is another type of model to study infectious diseases.  In this model, the 
infected will return to the susceptible class after recovery.  This model is more effective to use 
when studying sexually transmitted diseases.  The simplest model, which was also given by 
Kermack and McKendrick is: 
 dS SI aI
dt
β= − +  (2.15) 
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 dI SI aI
dt
β= −  (2.16) 
This model is different than the SIR model in that the recovered members will return to the 
susceptible class at a rate of aI instead of moving to a recovered class.  Just as in the SIR model 
the total population is constant, since ( )S I 0′+ = .  Again, let the constant population be 
represented by K.  If , we can replace S by K-I and reduce the model to a single 
differential equation.  This equation is: 
K S I= +
 2
( )
( )
( ) (1
dI I K I aI
dt
K a I I
IK a I aK
β
β β
β )
β
= − −
= − −
= − −
−
 (2.17) 
This is a logistic equation with a growth rate of K aβ −  and a carrying capacity of aK β− .  An 
analysis of this will show that if 0K aβ − <  or 1K
a
β < , then for any , we see that 
 and l .  If 
0 0I >
lim ( ) 0
t
I t→∞ = im ( )t S t K→∞ = 1
K
a
β > , then for any , we will see that 0 0I > lim ( )t
aI t K β→∞ = −  
and lim ( )
t
aS t β→∞ = .  As seen here, there is a single limiting value for I and this limiting value is 
determined by the quantity, K
a
β , regardless of the initial rate of infection.  The infection will 
disappear or the number of infected will approach zero when 1K
a
β < .  Hence the equilibrium 
I=0 and S=K is considered the disease free equilibrium.  If 1K
a
β > , the infection will continue.  
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The equilibrium, I K
a
β= − , which corresponds to aS β= , is defined as the endemic 
equilibrium. 
 The dimensionless quantity, K
a
β , is the reproduction number for our system, noted as 
0
KR
a
β= .  In Section (2.2), we discussed that the value of 0R  was the threshold parameter.  We 
also defined 0R , as the number of secondary infections produced by one primary infection in the 
population of susceptible.  The reproduction number helps determine the path which the disease 
will take.  If 0
KR
a
β= , where Kβ is the number of contacts made by an average infected per 
unit of time and 1
a
 is the mean infected period, we can clearly see if 0 1R < , the infection will 
disappear and if , the infection will persist. 0 1R >
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CHAPTER THREE – INTRA-HOST DYNAMICS OF HIV 
3.1 Introduction to intra-host dynamics of HIV 
To understand how HIV destroys the immune system, we first must understand how the 
immune system works.  When a foreign substance, or antigen, enters the body, the body will 
initiate an immune response.  This immune response starts with macrophages and monocytes.  
These cells are the body’s first defense against the antigen.  They will seek out the antigen, 
surround it and overtake it.  This process is known as phagocytosis.  The macrophages will then 
analyze the content of the antigen and pass this information along to the CD4+ T lymphocytes, 
also called CD4+ T cells.  The CD4+ T cells will call for the production of more CD4+T- cells 
or will call for the production of types of T-cells such as the CD+8-T cells.  Another weapon 
used by the body’s defense system is the B lymphocytes or B cells.  These cell produce 
antibodies specifically engineered to destroy the pathogen detected by the macrophages. (See 
[7]) 
HIV is considered a lentivirus, meaning slow virus, which is a subclass of the retrovirus.  
In general, a virus will insert their own DNA into the host cell.  When the host cell replicates 
their DNA, the virus’ DNA is also replicated.  A retrovirus, like HIV, will insert RNA rather 
than DNA into the host.  Retroviruses have a unique enzyme , reverse transcriptase. (See [5]).  
This enzyme will prepare a DNA copy of the RNA genome into the host.  This DNA copy is 
eventually inserted into the genome of the host cell where the virus will persist for years and is 
impossible to eradicate. (See [19])  The HIV DNA will get copied every time the host cell 
divides. 
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On the cellular level, the HIV particles target the CD4+ T lymphocyte.  It attracts the 
CD4+T-lymphocyte through a glycoprotein called gp120.  The protein enzyme, gp120, is located 
on the surface of the HIV particle and it is attracted to the CD4 protein on the surface of the T-c 
ells, macrophages, and monocytes.  The CD4+ T cell attaches itself to the virus and is infected. 
The HIV infection can typically be divided into three phases.  The first phase is the 
primary infection.  During this initial phase, the virus is present in the host and replicates in the 
manner describe previously.  Three to six weeks after infection, 50-75% of patients develop an 
acute viral syndrome. (See [19])  There is also a significant reduction of CD4+ T cells.  The 
second phase of HIV infection is the longest phase.  It is the phase in which there is a long 
asymptomatic period and latency occurs.  There are two major features of this phase.  The first 
feature is the permanent viral replication in the lymphatic tissue and lymphoid organs.  The 
second feature is the gradual decline of the CD4+ T cells.  The final phase of the HIV infection 
shows a sharp decline of CD4+ T cells and the emergence of clinical immunodeficiency and 
progression to AIDS.  The period of time from initial infection to the formation of AIDS can 
vary from person to person.  The median estimate is eight to eleven years without treatment and 
even longer with treatment. 
3.2 HIV Simple Model 
Stilianakis and Schenzle developed this basic model to describe the long term dynamics 
of HIV progression through the body and the eventual development of AIDS.  The basic 
biomedical assumption of this model is the genetic variation of HIV.  It is assumed that the 
infection rate is the major source for the increase and selection of the HIV mutants. 
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Table 1: Variables used in the simple model 
 
 Variable  
X Total number of susceptible CD4+ T cells 
Y Total number of productively infected CD4+ 
T cells 
V Total number of HIV particles 
K Factor that describes the increase of the 
CD4+ T cell infection rate 
 
 
 
 
The model consists of the following non-linear differential equations: 
 0
dX X KVX
dt
μ κ= Λ − −  (3.1) 
 0
dY KVX Y
dt
κ δ= −  (3.2) 
 dV Y V
dt
β γ= −  (3.3) 
 max(K
dK V K K
dt
ω= )−  (3.4) 
 The biological representation of each term in each equation will now be discussed in 
order to provide a better understanding of the system.  In the first equation, equation (3.1), Λ 
represents the constant rate at which new CD4+ Tcells are produced.  These newly produced 
CD4+ T cells are considered to be susceptible.  The term μX is the rate at which susceptible cells 
die.  The last term, , is considered a mass action term which describes the rate at which 
susceptible cells are infected by the HIV particles.  This mass action term is also seen in the first 
term of equation (3.2).  The second term in equation (3.2) is 
0KVXκ
Yδ .  This term describes the death 
rate of the infected CD4+ T cells. 
 The first term in equation (3.3) is βY.  This term represents the rate in which infectious 
viral particles infect the CD4+ T cells.  γV represents the rate at which virus particles are cleared.  
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In the last equation, equation (3.4), one term is seen.  This equation represents how fast the virus 
can reproduce within the host and the maximum amount of virus particles that can be see within 
the host at any particular time within the evolutionary process. 
 The rate at which the virus reproduces is called the virus reproduction number.  In this 
model it is a dynamic quantity and it changes over time.  The virus reproduction number is: 
 00
( )( ) K t XR t 0βκ δγ=  (3.5) 
This reproduction number will increase monotonically toward: 
 * 0 max 00
K XR βκ δγ=  (3.6) 
3.3 HIV Extended model 
The following model is an extension of the original basic model.  The extended model 
takes into account the total number of susceptible CD4+ T cells and how fast new CD4+ T cells 
become susceptible to the HIV infection.  
Table 2: Variables used in the extended model 
 
Variable  Initial Values 
X Total number of non-susceptible CD4+ T 
cells 
11
0(0) 0.7 2.5 10X X= = × ×  
S Total number of susceptible CD4+ T cells 11
0(0) 0.3 2.5 10S S= = × ×  
Y Total number of productively infected 
CD4+ T cells 
0(0) 0Y Y= =  
V Total number of HIV particles 0(0) 1V V= =  
Z Anti-HIV activity of the immune system 6
0(0) 10Z Z
−= =  
P Fraction of new CD4+ T cells entering the 
pool of susceptible CD4+ T cells 
0(0) 0.3P P= =  
K Factor that describes the increase of the 
CD4+ T cell infection rate 
0(0) 1.0K K= =  
N Total number of uninfected CD4+ T cells 11
0 0 0(0) 2.5 10N N X S= = + = ×  
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The model consists of the following non-linear differential equations: 
 (1 )dX P
dt
Xα μ= − −  (3.5) 
 0 ( )
dS SP S KV
dt P d
α μ κ= − − +  (3.6) 
 0 (( ) Y Y
dY SKV Z Y
dt P d
κ μ= − ++ )δ  (3.7) 
 ( V V
dV Y
dt
β μ δ= − + )Z V  (3.8) 
 max( ) [ ( ) ]
dZ g V f S X Z Z
dt
θ ρ= + + −  (3.9) 
 max(P
dP V P P
dt
ω )= −  (3.10) 
 max(K
dK V K K
dt
ω= )−  (3.11) 
where 
 1( )
01 ( )
cbf N bN c
N
+=
+
 and ( ) Vg V
a V
= +  (3.12) 
N can be divided into the number of non-susceptible T cells, X, and the number of susceptible T 
cells, S.  Therefore, N=X+S.   
To understand the system, an understanding of what each term biologically represents 
must first be presented.  In equation (3.5), P is the fraction of new CD4+ T cells that enter the 
susceptible and 1-P is the fraction of new CD4+ T cells that remain unsusceptible to the HIV 
virus.  The first term in equation (3.5) is α(1-P) where α is the T cell production rate.  This term 
represents the immigration rate of new non susceptible T cells.  The second term is μX in which 
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μ is the natural death rate of the unsusceptible cells.  Therefore, this term represents how many 
non susceptible CD4+ T cells die. 
Equation (3.6) represents the dynamics of the susceptible cells in the system.  The first 
term, αP, describes the immigration rate of the susceptible CD4+ T cells.  The second term, μS, 
represents the natural death rate of the susceptible cells.  The last term in equation (3.6) is 
0 ( )
SKV
P d
κ + .  This is a mass action term which describes the infection process between cells 
and viruses.  In particular, 
( )
S
P d+  describes the dynamics changes in the susceptible cells.  The 
variable, P, in this term is very important in helping determine the course of the infection and the 
progression of the disease.  In fact, P shows that more cells can be attacked and infected by the 
virus than the immune system can combat.   
Equation (3.7) has many terms and this equation determines how many productively 
infected cells are in the blood.  The first term is the same mass action term that is seen in 
equation (3.6).  The second term in equation (3.7) is ( )Y Y Z Yμ δ+ .  Yμ  represents the death rate 
of productively infected cells and Y Zδ  represents how fast these dead cells are removed from the 
system.  Equation (3.8) describes the number of HIV particles that are produced and destroyed.  
The first term in equation (3.8) is Yβ .  In this term, β, describes the rate at which HIV particle 
cells are produced from infected cells.  The second term, ( )V V Z Vμ δ+ , describes the rate at 
which HIV particles are cleared and eliminated.  Vμ  is the rate in which virus particles are 
cleared and V Zδ  represents the anti-HIV activity and elimination. 
Equation (3.9) is the most complicated equation within the model because not much is 
known about the dynamics of the HIV specific immune response, therefore, a general equation is 
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used to model this response.  The equation shows the coupling of a time dependent decline of the 
CD4+ T cells and the intrinsic features of the immune response.  The variable, ρ, in equation 
(3.9) represents the HIV specific immune response.  This response occurs independently of the 
number of HIV particles that are present in the body.  The function, g(V), models how the 
immune response is activated depending on the quantity of the virus.  The term, 
max[ ( ) ]f S X Zρ + , is the rate once primary infection occurs in which HIV will start producing 
specific antibodies and the cytotoxic cells will start multiplying.  Once this occurs, the immune 
system will eventually become independent of the number of HIV particles and infected cells.  In 
equation (3.9), the function f(N) describes how the activity of the immune system is related to the 
number of available uninfected cells.  This function also takes account of the immune system’s 
ability to combat HIV when the number of CD4+ T cells is not sufficiently high.   
Equation (3.10) describes the increase in the rate of the fraction of new cells coming from 
the pool of susceptible cells and how they correspond to the generation and selection of HIV 
mutants.  Equation (3.10) describes the rate at which the HIV infection increases due to the 
reproduction of each virus particle. 
The virus reproduction number is also an important value to discuss.  The reproduction 
number represents how quickly the virus is reproducing.  The HIV reproduction number must be 
above one in order to show a persistent infection.  The virus reproduction number for this model 
is: 
 00 ( )( )(Y Y V V
KSR
)Z Z P d
βκ
μ δ μ δ= + + +  (3.13) 
If the values, S, Z, K could be held at fixed values, , , ,S Z K P , the biological interpretation would 
be that one HIV particle will generate 0R  secondary particles into the host.  At initial HIV 
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infection with time, t, equal to 0, the virus reproduction number has a value of 10 and is 
represented by the following equation: 
 
 0 00
0( )(Y V
SR
P d )
βκ
μ μ= +  (3.14) 
This is the initial reproduction number with no anti-HIV activity.  A reproduction number which 
represents the presence of a fully activated anti-HIV activity with a maximum number of 
susceptible cells can also be found.  The reproduction number with maximum anti-HIV activity 
is represented by the following equation: 
 
 0 0
0( )( )(Y Y V V
SR
P d )
βκ
μ δ μ δ′ = + + +  (3.15) 
In this equation, Z and K are held at fixed values, max 1Z Z= =  and 1K = .  If R′ is greater than 
one, the infection will persist and cannot be cured.  The calculated value of R′  is 2.75.  This 
value confirms that a patient with HIV will not be able to overcome the infection. 
The HIV extended model is very complex and a full mathematical analysis is not 
possible.  However, this model is also more realistic and applicable because it takes into account 
the difference between susceptible and non susceptible CD4+ T cells.  Modeling with specific 
parameters will help explain the system better.  Most of the parameters used were found through 
clinical and experimental data. (See [19])  The parameter values are described in Table 3: 
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Table 3: Parameter Values used in the extended model 
 
Parameter  Values 
α  CD4+ T cell production rate 95 10× per day μ  Natural death rate of uninfected cells 0.02 per day 
0κ  Initial rate at which a HIV particle 
transforms a susceptible CD4+ T cell to a 
productively infected cell 
121.0 10−×  particles per day 
Yμ  Death rate of productively infected cells 0.6 per day 
0.6 per day Yδ  Maximum additional elimination rate of 
productively infected cell through anti-HIV 
activity 
β  HIV production rate from infected cells 150 particles per cell per day 
Vμ  Clearance rate of infectious virus particles 6 per day 
Vδ  Maximum additional elimination rate of 
virus particles through the anti-HIV activity 
5 per day 
θ  HIV dependent immune activation rate 610−  ρ  Autonomous immune activation rate 0.1 per day 
Pω  Rate of increase of the fraction of 
susceptible cells by generation and selection 
of HIV mutants 
141.4 10−×  particles per day 
Kω  Rate of increase of reproduction per virus 
particle 
151.1 10−×  
a Constant 310  
b Constant 0.2 
c Constant 2.0 
d Constant 210−  
maxZ  Maximum ant-HIV activity 1.0 
maxP  Maximum fraction of susceptible cells 1.0 
 
maxK  Maximum infection rate of susceptible cells 
per infected cell 
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3.4 HIV Extended model Graphs and Biological Interpretation 
 The numerical results of the model using the parameter values from Section 3.3 were 
used to make the following graphs.  Figure 1 represents the number of CD4+ T cells.  Figure 2 
represents the number of HIV particles.  Figure 3 represents the anti-HIV activity.  Each of the 
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graphs represents the initial phase of the HIV infection within the first six months and supports 
the model predictions. 
 During primary infection there are a large number of virus particles which enter the body 
and start infecting the CD4+ T cells.  At the start of the infection, the number of HIV particles 
grows exponentially.  The HIV viremia causes a temporary reduction of CD4+ T cells which 
then recover and remain at a lower level than before the infection.  Notice in Figure 1 and Figure 
2 the increase and decrease of HIV particles and CD4+ T cells occurs at the same time around 15 
days.  Right after the initial infection, the anti-HIV activity mounts an attack against the invading 
virus particles and we see a resurgence of CD4+ T cells.  The anti-HIV activity increases rapidly 
and then reaches its max.  The anti-HIV activity is not the only reason the viremia starts to break 
down.  Note there are only a certain number of available CD4+ T cells to infect. 
 
Figure 1:  Decline of CD4+ T cells over first six months after initial infection. 
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Figure 2:  Increase in HIV particles within the first six months of infection. 
 
Figure 3:  Decline of anti-HIV activity within the first six months of initial infection. 
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 During the second phase of the infection for about ten years, the virus is slightly 
suppressed and increases slowly.  This is the latent period of the infection.  The model shows the 
immune system will hold to 50% of the normal value for about 10 years but will drop 
significantly during the two years following.  After about twelve years, the CD4+ T cells will 
drop below 20% which is the definition of disease progression to AIDS. (See [19]).  We see a 
decline of anti-HIV activity.  The HIV virus particles replicate freely and reach a higher 
concentration than that of the primary infection.  At this point, the immune system can’t control 
other infections. 
 
Figure 4:  Total cell count after 12 years.  Progression to AIDS occurs at y=0.2 
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Figure 5:  Anti-HIV activity after 12 years. 
 
Figure 6:  HIV particle increase over 12 years. 
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Surprisingly, the model predicts that the initial dose of HIV particles introduced into the 
host does not play an important role in progression to disease.  A highly activated CD4+ T cell 
pool is one of the main determinants to infection and disease progression.  If an individual is 
unhealthy, their CD4+ T cell pool would be larger than normal and would favor CD4+ T cell 
infection by the HIV virus.  If an individual has an initial value of 1200 per  CD4+ T cells, 
then the progression to disease occurs much faster.  If the initial value was 800 per  CD4+ T 
cells a much smoother progression occurs.  The following graph shows the impact of initial cell 
count on the infection process. 
3mm
3mm
 
Figure 7:  Total CD4+ T cell count after a 20% reduction of CD4+ T cell count (aqua), normal 
reduction (blue), and initial increase by 20% of CD4+ T cell count (red). 
 
 This model also looks at the dynamics of the susceptible and non-susceptible cells.  The 
variable, P, in the model represents the proportion of new CD4+ T cells which are becoming 
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susceptible.  The higher the amount of activated CD4+ T cells, the faster the virus progresses to 
disease.  The initial value of P is important to the dynamics of this model.  If the initial value of 
P is small, the immune system will hold at 50% for about twelve years.  However, if P is a larger 
fraction, the progression to disease is much faster.  This means through the generation and 
selection of HIV mutants, the HIV virus will increase the range of CD4+ T cells tropism over 
more and more CD4+ T cell clones, until after twelve years almost all of the clones are equally 
susceptible to be infected by the HIV virus. (See [19])  The variable, K, is the factor which 
represents the infection rate at which the CD4+ T cells increase by the generation and selection 
of HIV mutants. 
 
Figure 8:  Changes in the P value and the impact on the total cell count. 
 
 The speed at which P and K change are measure by Pω  and Kω .  These values also play 
an important role in the model and the disease progression.  If the value of Kω  were increased or 
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decreased by a factor of five, the reduction rate of the CD4+ T cells would look similar but the 
end result make be different.  If Kω  was decreased by a factor of five, the model predicts the 
individual’s life span would increase by two years.  If Kω  was increased by a factor of five, the 
model predicts a faster progression to disease around eight years.  There is a stark difference 
when the value of Pω  is changed by a factor of five.  If Pω  is increased by the factor, 
progression to disease occurs after six years. 
 
Figure 9:  Impact on CD4+ T cells when the values of Kω  are varied. 
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Figure 10:  Impact on CD4+ T cells when the value of Pω  is varied. 
 As seen through the graphs, P,K, Pω , and Kω  are very important to the intra-host 
dynamics of HIV.  The effect of the rate of the fraction of susceptible cells by generation and 
selection of HIV mutants is very important in determining the progression to disease. (See [19])   
HIV will affect many people in many different ways.  This model helps to predict the 
course that HIV will take during the three stages of the disease.  The model may loose 
applicability for the late part of the last stage of the disease because of the many other extreme 
pathological conditions.  In the latter stage of the disease, the immune system is completely 
compromised and is no longer able to fight infection.  When this happens, a simple cold could 
cause death.  Understanding the course of this disease through the model presented can help 
doctors and scientist find a cure for this epidemic. 
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CHAPTER FOUR – HTLV-I VIRUS AND ADULT T-CELL LEUKEMIA 
4.1 Introduction to the dynamics of HTLV-I 
As we have seen in the previous chapter, the HIV infection takes place through cell to 
cell contact with infected CD4+ T-cells and eventually takes over the immune system.  A virus 
that is similar and related to HIV is the first form of a human T-lymphotropic virus or HTLV.  
Just as HIV can lead to the AIDS virus, HTLV-I can lead to many diseases, including adult T-
cell leukemia/lymphoma.  Actively infected T-cells can infect other T-cells and can eventually 
convert to ATL cells.  This process typically happens during the latent phase of the virus.   
HTLV-I shares many similarities with HIV except in the range of diseases that it causes 
and how it causes these diseases.  There are two major virologic differences between HIV and 
HTLV-I.  One difference is that HTLV-I does not destroy the CD4+ T-cells but in fact, causes 
cell proliferation and transformation.  The other is that HTLV-I has a low replication rate but a 
high fidelity of replication, which results in a low viral burden and high genetic stability.  This 
reduces the possibility of immune escape. (See [14])   
HTLV-I is an enveloped double stranded RNA retrovirus which attacks the CD4+ T-
cells.  Transmission of HTLV-I is mainly associated with the cells.  The cells receive this virus 
through a glucose transporter called glut-1.  Once received, the virus inserts a DNA copy into the 
host cell.  The virus replicates with each mitotic cell division.  As cells continue to divide, the 
virus spreads.  HTLV-I will remain latent for many years before the virus causes Adult T-cell 
leukemia to manifest.  The latently infected cells contain the virus but do not produce DNA, 
therefore, the cells are incapable of contagion.  This chapter examines a math model which 
examines the process of how HTLV-I causes ATL. 
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Adult T-cell leukemia or lymphoma is a non-Hodgkins lymphoma.  Adult T-cell 
leukemia occurs first, which is a cancer of the cells.  Lymphona also occurs and is a cancer 
which attacks the B-lymphocytes and the lymphatic system.  There are four distinct clinical 
forms of ATL.  The disease can be classified as acute ATL, chronic ATL, lymphoma, and 
smoldering ATL.  Once ATL develops, most individuals will survive for only a year or two.  The 
median survival rate for the acute and lymphoma subtypes is less than one year.  Individuals with 
acute or smoldering ATL may survive longer. (See [8])  Standard chemotherapy is not effective 
against ATL. 
4.2 Mathematical Model of HTLV-I Infection to ATL 
Stilianakis and Seydel produced a basic math model that describes the T-cell dynamics of 
the HTLV-I infection and the development of ATL.   
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Table 4: Variables used in the Stilianakis & Sydel model 
 
 Variable  
T Number of susceptible CD4+ T cells 
 Number of latently infected CD4+ T cells LT  
Number of actively infected CD4+ T cells AT   
Number of leukemia T-cells MT  
 Λ Constant rate at which new CD4+ Tcells are 
produced (assumed to be susceptible) 
 κ Rate at which CD4+ T cells come into 
contact with actively infected cells. 
 α Transmission rate in which latent cells 
become actively infected cells 
 ρ Transmission rate in which actively infected 
cells convert to ATL cells 
 β ATL proliferation rate of a classical logistic 
growth model 
 Removal or death rate of susceptible 
CD4+T-cells 
Tμ  
 Removal or death rate of latently infected 
CD4+ T cells 
Lμ  
 
Aμ  Removal or death rate of actively infected 
CD4+ T cells  
 
This model consists of the following non-linear differential equations: 
 TT T AT Tμ κ′ = Λ − −  (4.1) 
 ( )L A LT T T TLκ μ α′ = − +  (4.2) 
 ( )A L AT T TAα μ ρ′ = − +  (4.3) 
 
max
(1 )MM A M M
M
TT T T T
T
ρ β μ′ = + − − M  (4.4) 
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The terms in this model each have a biological meaning.  The first term in equation (4.1) 
is Λ .  This term is the rate in which the new CD4+ T cells are produced.  Each cell that is 
produced is assumed to be susceptible to the virus.  The second term in equation (4.1) represents 
the rate at which all CD4+ T cells die.  The last term in equation (4.1) is AT Tκ  and is considered 
the mass action term.  This term represents the infection process of susceptible cells which come 
into contact with actively infected CD4+ T cells.   
Equation (4.2) starts with the same mass action term that is seen in equation (4.1).  The 
second term is ( )L TLμ α+ .  Lets break this term up into two terms, L LTμ  and LTα  and explain 
them separately.  L LTμ  describes how fast the latently infected cells are dying.  LTα  describes 
how fast the latently infected cells become actively infected cells.  In general, the whole term 
describes the dynamics of the latently infected cells. 
The first term in equation (4.3) is LTα .  As seen in equation (4.2), this term represents 
how fast the latently infected cells become actively infected cells.  The next term is ( )A ATμ ρ+ .  
Again, lets break this up into two terms, A ATμ  , which describes the death rate of the actively 
infected cell, and ATρ , which describes how fast the actively infected cells become ATL cells.  
The terms in equation (4.3) represent the dynamics of the actively infected cells and how they 
change to ATL cells. 
Equation (4.4) is the equation which represents the growth of the leukemia cells, which 
follows the classical logistical growth function.  This equation begins with ATρ .  This term was 
also seen in equation (4.3) and it describes the speed at which actively infected cells become 
ATL cells.  The second term is 
max
(1 )MM
M
TT
T
β − .  This term describes the growth of the ATL cells, 
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where β  is the speed for which the saturation level for leukemia cells is reached and  is the 
maximum amount of ATL cells that can be attained.  The last term,
maxM
T
M MTμ , describes the death 
rate of the ATL cells.  This equation illustrates the dynamics of the ATL or leukemia cells in the 
body. 
The virus reproduction number for this model is: 
 00 ( )(L A
TR
)
ακ
μ α μ ρ= + +  (4.5) 
This number helps to determine how fast the disease will spread throughout the body.  0R  
represents the number of secondary infections caused by one primary infected cell introduced 
into the pool of susceptible CD4+ T cells during the infection period. (See [18])  If , a 
chronic infection is seen.  This is typical in most HTLV-I infections.  If , the virus cannot 
reproduce enough to sustain an infection.  The reproduction number will be important to 
determining the stability of the system. 
0 1R >
0 1R ≤
 
4.3 Stability of the system 
To analyze the stability of this system, we must first find the equilibrium points.  In order 
to find the equilibrium points, we set equations (4.1)-(4.4) equal to 0 and solve.  The equation 
has two possible solutions or steady states.  This system can have an uninfected steady state and 
a positively infected steady state.  For the uninfected steady state, the T-cell population will have 
the following value: 
 0
T
T μ
Λ=  (4.5) 
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The initial conditions would then be 0(0)T T= , (0) 0LT = , (0) 0AT = , and .  Therefore 
the uninfected steady state would be 
(0) 0MT =
0 0( ,0,0,0)E T= .  The positive infected steady state would 
be ( , , , )L A ME T T T T=  where: 
 
max max2
( )( )
( )( )
( )
( )( )
( )( )
( )
0
L A
T L A
L
L
T L A
A
L A
M M A M
M M
T
T
T
T T T
T T
μ α μ ρ
ακ
ακ μ μ α μ ρ
ακ μ α
ακ μ μ α μ ρ
κ μ α μ ρ
β μ ρ
β β
+ +=
Λ − + += +
Λ − + += + +
−− − =
 (4.6) 
We are first going to examine the stability of the uninfected steady state.  For this state, 
the values yield the following Jacobian matrix associated with equations (4.1)-(4.4):  
 
 
max
0 0
0
0 0
0 0 1 2
T A
A L
A
M
M
M
T T
T T
J
T
T
μ κ κ
κ α μ κ
α μ ρ
ρ β μ
− − −⎛ ⎞⎜ ⎟− −⎜ ⎟⎜ ⎟− −= ⎜ ⎟⎛ ⎞⎜ ⎟− −⎜ ⎟⎜ ⎟⎜ ⎟⎜ ⎟⎝ ⎠⎝ ⎠
 (4.7) 
 
In the uninfected steady state, the characteristic of the polynomial is found by taking the 
determinant of the Jacobian or det ( )J Iλ− .  The characteristic polynomial is: 
 2( ) ( )( )( ( ) ( )( )M T L A L Ap λ β μ λ μ λ λ λ μ α μ ρ μ α μ ρ ακ= − − − + + + + + + + −  (4.9) 
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The eigenvalues of ( ) 0p λ =  are: 
 
2
3,4
1
2
( ) 4(( )( )
( )
2 2
L A L A
TL A
M
T
μ μ α ρ μ α μ ρ ακ μμ α μ ρλ
λ β μ
λ μ
Λ+ + + − + + −− + + += ±
= −
= −  (4.10) 
The eigenvalues help determine the stability of the steady state.  If 1 0Mλ β μ= − >  , then the 
proliferation rate of the abnormal cells are greater than the death rate and the infection increases.  
If 1 0Mλ β μ= − <  , then the death rate of the ATL cells is greater than the proliferation rate and 
the stability will actually depend on the other eigenvalues, 3 4,λ λ .  These eigenvalues are either 
real or complex conjugates.  In both cases, the real parts are negative if and only if the 
reproduction number is less than or equal to one or: 
 00 1( )( )L A
TR ακμ α μ ρ= ≤+ +  (4.11) 
 
If we assume that the ATL cells grow at an uncontrollable rate, then 1 0λ >  and the point, 
, where 0 0( ,0,0,0)E T= 0
T
T μ
Λ= , is an unstable saddle point.  If 1 0λ < , the reproduction number 
will determine the next steady state.  If 0 1R ≤  the uninfected steady state is the only state and it 
is stable.  The system will move to the endemically infected steady state when  and this 
represents a chronic infection.  When this occurs,  will become unstable and 
0 1R >
0E E  will exist. 
For the endemically infected steady state, the Jacobian and the determinant of equations 
(4.1)-(4.4) will give the following characteristic equation: 
 3 2 0A B Cλ λ λ+ + + =  (4.12) 
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Where: 
 
T L A A
T L T T L A A A A A
L A A A A L A A
A T
B T T T
C T T T T
μ μ μ ρ α κ
Tμ μ αμ μ ρ κμ κμ κρ ακ
κμ μ καμ κρμ ακρ
= + + + + +
= + + + + + +
= + + +
 (4.13) 
We must use the Routh-Hurwitz condition in order to further determine the stability of the 
system.  Note that  and   By the Routh-Hurwitz criteria, the eigenvalues of 
equation (4.12) will have negative real parts if and only if  and .  We 
have already noted that  and .  We can also show 
0, 0A B> > 0C >
0, 0A C> > 0AB C− >
0A > 0C > 0AB C− > , therefore, we can 
determine that the eigenvalues are always negative.  When the eigenvalues are negative, we can 
show that steady state is stable and the infection is chronic. 
4.4 Katri and Ruan Model and the stability of the system 
In 2004, Katri and Ruan developed a similar model which takes into account the 
difference between contact with the virus and infection by the virus.  This is denoted using a 1κ  
in certain equations.  Remember that κ  represents the rate at which uninfected cells are 
contacted by actively infected cells.  In this model, 1κ  represents the rate of infection of the T-
cells by the actively infected T-cells.  The equations for the Katri and Ruan model are the same 
as the original model but in equation (4.2) κ  is replace with 1κ  and the new model is: 
 TT T AT Tμ κ′ = Λ − −  (4.14) 
 1 ( )L A LT T T LTκ μ α′ = − +  (4.15) 
 ( )A L AT T TAα μ ρ′ = − +  (4.16) 
 
max
(1 )MM A M M
M
TT T T T
T
ρ β μ′ = + − − M  (4.17) 
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This small change in the model changes the reproduction number to be: 
 1 00 ( )(L A
TR
)
ακ
μ α μ ρ= + +  (4.18) 
 The uninfected steady state and stability analysis remains the same as the Stilianakis & 
Seydel model, however the new positive infected steady state would be ( , , , )L A ME T T T T=  
where: 
 
max max
1
1
1
2
( )( )
( )( )
( )
( )( )
( )( )
( )
0
L A
T L A
L
L
T L A
A
L A
M M A M
M M
T
T
T
T T T
T T
μ α μ ρ
ακ
ακ μ μ α μ ρ
ακ μ α
ακ μ μ α μ ρ
κ μ α μ ρ
β μ ρ
β β
+ +=
Λ − + += +
Λ − + += + +
−− − =
 (4.19) 
For this state, the values yield the following Jacobian matrix associated with equations (4.14)-
(4.19): 
 
max
1 1
0 0
0
0 0
0 0 1 2
T A
A L
A
M
M
M
T T
T T
J
T
T
μ κ κ
κ α μ κ
α μ ρ
ρ β μ
⎛ ⎞− − −⎜ ⎟− −⎜ ⎟⎜ ⎟− −= ⎜ ⎟⎛ ⎞⎜ ⎟− −⎜ ⎟⎜ ⎟⎜ ⎟⎜ ⎟⎝ ⎠⎝ ⎠
 (4.20) 
We will denote: 
 
max
(1 2 )M M
M
TM
T
β μ′ = − −  (4.21) 
Then the eigenvalues of this Jacobian are M ′ .  These eigenvalues will always be negative since 
maxM M
T T> when the infection is chronic.  The Jacobian will yield the following characteristic 
equation: 
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  (4.22) 3 2 1 2 4 3 5( ) ( )a a a a aλ λ λ+ + + + + = 0
Where: 
 
2
1
2 2 2 2
2
2 2
3
2
4 1 1 1 1
5 1 1
( )
(
A L T A
A L A T L A A A
A L T A T L A T
T A A A T A L
T L T A A L L A
L A L A
T T A
a T
a T T T T
a T T
T
a
a
κ κμ κρ κμ ακ κμ
κ μ κ α μ κμ κ μ κ ρ
μ κμ μ κα μ κμ κμ ρ καμ καρ μ κρ
μ καρ κ αρ κ μ α μ μ κμ
μ κμ ρ μ καμ κ μ ρ μ μ
κ αρ κ μ ρ κ αμ κ μ μ
μ κ αρ μ μ κ
= + + + + +
= + + + + +
+ + + + + +
= + + +
+ + + +
= − − − −
= − + 1 1 )L T L T Aμ μ κ μ ρ μ κ αμ+ +
 (4.23) 
Note:  The coefficients were written in this manner for convenience and comparison in some 
later work by Katri & Ruan. 
Again, we must use the Routh-Hurwitz condition in order to further determine the stability of the 
system.  According to the Routh-Hurwitz condition, the eigenvalues of equation (4.23) will have 
negative real parts if and only if: 
 1 3 5
1 2 4 3 5
0, ( ) 0
( ) ( )
a a a
a a a a a
> + >
0+ − + >  (4.24) 
 Proposition 1:.The infected steady state E  is asympototically stable if  and the 
inequalities in (4.24) are satisfied.  This occurs if (a) 
0 1R >
1κ κ> , or (b) 1κ κ= .(See [6]) 
.In order or check that this proposition is valid, we will use the following parameters and values 
estimated by Stilianakis & Seydel (See [18]). 
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Table 5: Variables and Parameter Values for contagion used in the model 
 
Parameter  Values 
T  Uninfected CD4+ T-cell population size 31000 / mm  
LT  Latently infected CD4+ T-cell density 3250 / mm  
AT  Actively infected CD4+ T-cell density 31.5 / mm  
MT  Leukemic CD4+ T-cell density 0 
Tμ  Natural death rate of CD4+ T-cells 30.6mm  per day 
Lμ  Blanket death rate of latently infected CD4+ 
T-cells 
0.006 per day 
Aμ  Blanket death rate of actively infected cells 0.05 per day 
Mμ  Death rate of leukemic cells 0.0005 per day 
1κ  Rate uninfected CD4+ T-cells become 
latently infected 
varies 
κ  Rate infected cells are contacted varies 
β  Growth rate of leukemic CD4+ T-cell 
population 
0.0003 per day 
α  Rate latently infected cells become actively 
infected 
0.0004 per day 
ρ  Rate actively infected cells become 
leukemic 
0.00004 per day 
maxM
T  Maximal population level of leukemic 
CD4+ T-cells 
32200 / mm  
λ  Source term for uninfected CD4+ T cells 6 per day 
 
0T  Derived quantity which represents the 
CD4+ T-cell population for HTLV-I 
negative persons 
31000 / mm  
We can use these parameter values and the estimated values of κ  and 1κ , given by Stilianakis & 
Seydel on the basis of parameter values from the HIV infection process, to find that 0 1.25R =  if 
.  If we take 1 0.1κ = 1 0.1κ κ= = , we find that the inequalities in equation (4.24) are satisfied and 
part (b) of Proposition 1 is true.  Furthermore, the steady state, (800,187.5,1.5,1.3)E = , would 
be asymptotically stable.  If we take 0.5κ =  and 1 0.1κ = , we will again find that the inequalities 
in equation (4.24) are satisfied and part (a) of Proposition 1 is also true.  The steady state would 
be (800,37.38,0.3,0.6)E = , which is also asymptotically stable.  The following graph was 
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created using the parameter values given in Table 5.  The numerical simulation shows the 
number of healthy CD4+ T cells decreases dramatically while the latently infected cells increase, 
then remain steady. 
 
Figure 11:  Latently infected CD4+ T cells vs. Uninfected CD4+ T cells 
 
 HTLV-I is a virus in which only 5% of infected individuals will ever develop any disease 
such as Adult T-cell Leukemia.  We have shown through the stability analysis, we can predict 
when the infection will persist and become ATL. 
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CHAPTER FIVE - CONCLUSION 
 The interaction between HIV and the immune system is a dynamic process.  
Mathematical models are used to understand this process and explore which biological 
mechanisms cause disease progression.  There is no cure or vaccine for HIV at the present time, 
but the treatment regimes used by doctors extend the lives of HIV patients.  Doctors are also 
working to find a vaccine.  Future work should be focused on finding the optimal treatment 
schedule in order to prolong the life of patients and hopefully, find a cure.  
 It is unclear why some HTLV-I carriers progress to disease while the majority of them do 
not do so.  It is also not known why some infected individuals develop ATL and others develop 
HAM/TSP. (See [8]). Further studies should focus on finding the mechanism, which causes the 
virus to progress to disease and finding the genetic markers that will determine which disease the 
virus will trigger.  HTLV-I also has no known cure or vaccine.  However, a vaccine to prevent 
infection is currently being explored by scientists. 
In this thesis we examined many mathematical models which are used to predict the 
course of a disease.  Specifically, we examined two retroviruses, HIV and HTLV-I.  A basic 
model and background study was given in Chapter Two.  Chapter Three explored a model of the 
intra-host dynamics of HIV.  Graphs which were obtained from each of the models help predict 
what factors are important for HIV to progress to AIDS.  Chapter Four is concerned with two 
different models of HTLV-I progression to ATL.  Using analytical techniques we study the 
stability and asymptotic stability and with the aid of SIMULINK, we obtain graphs associated 
with the models to obtain information on progression of the disease.  
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The mathematical models presented here are useful and can help predict the course of the 
infection.  However, as more clinical data about the virus becomes available, the models can be 
refined further to reflect the new information.  
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APPENDIX A 
SIMULINK OF STILIANAKIS AND SCHENZLE EQUATIONS 
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 Figure 12: Simulink of Stilianakis and Schenzle equations 
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APPENDIX B 
 MATLAB OF STILIANAKIS AND SCHENZLE EQUATIONS 
 47
clear all 
close all 
clc 
%first pass for plot of P=.1  in Figure 3 
%days for simulation to run 
days=4380; 
% defining variables 
alpha=5*10^9; 
mu=.02; 
k0=1*10^-12; 
mu_Y=.6; 
delta_Y=.6; 
beta=150; 
mu_V=6; 
delta_V=5; 
theta=10^-6; 
rho=.1; 
omega_P=1.4*10^-14; 
omega_K=1.1*10^-15; 
Zmax=1; 
Pmax=1; 
Kmax=20; 
a=10^3; 
b=.2; 
c=2; 
d=10^-2; 
% initial values of intergration 
N0=2.5*10^11; 
X0=.7*2.5*10^11; 
S0=.3*2.5*10^11; 
Y0=0; 
V0=1; 
Z0=10^-6; 
P0=.1; 
K0=1; 
% simulation 
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sim('untitled_P_01_08') 
% plotting 
t=X(:,1); 
x1=X(:,2); 
s1=S(:,2); 
y1=Y(:,2); 
v1=V(:,2); 
z1=Z(:,2); 
p1=P(:,2); 
k1=K(:,2); 
figure (8) 
hold on 
plot (t,(x1+s1+y1)/N0,'b') 
ylabel('(X+S+Y)/N0') 
xlabel('Time in days') 
title('Decrease of total cell count over time') 
%second pass for second plot on simulation with P=.8 from figure 3 
%days for simulation to run 
days=4380; 
% defining variables 
alpha=5*10^9; 
mu=.02; 
k0=1*10^-12; 
mu_Y=.6; 
delta_Y=.6; 
beta=150; 
mu_V=6; 
delta_V=5; 
theta=10^-6; 
rho=.1; 
omega_P=1.4*10^-14; 
omega_K=1.1*10^-15; 
Zmax=1; 
Pmax=1; 
Kmax=20; 
a=10^3; 
b=.2; 
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c=2; 
d=10^-2; 
% initial values of intergration 
N0=2.5*10^11; 
X0=.7*2.5*10^11; 
S0=.3*2.5*10^11; 
Y0=0; 
V0=1; 
Z0=10^-6; 
P0=.8; 
K0=1; 
% simulation 
sim('untitled_P_01_08') 
% plotting 
t=X(:,1); 
x1=X(:,2); 
s1=S(:,2); 
y1=Y(:,2); 
v1=V(:,2); 
z1=Z(:,2); 
p1=P(:,2); 
k1=K(:,2); 
plot (t,(x1+s1+y1)/N0,'g') 
%first pass for plot of omega_k  in Figure 6 
%days for simulation to run 
days=4380; 
% defining variables 
alpha=5*10^9; 
mu=.02; 
k0=1*10^-12; 
mu_Y=.6; 
delta_Y=.6; 
beta=150; 
mu_V=6; 
delta_V=5; 
theta=10^-6; 
rho=.1; 
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omega_P=1.4*10^-14; 
omega_K=1.1*10^-15; 
Zmax=1; 
Pmax=1; 
Kmax=20; 
a=10^3; 
b=.2; 
c=2; 
d=10^-2; 
% initial values of intergration 
N0=2.5*10^11; 
X0=.7*2.5*10^11; 
S0=.3*2.5*10^11; 
Y0=0; 
V0=1; 
Z0=10^-6; 
P0=.3; 
K0=1; 
% simulation 
sim('untitled_P_01_08') 
% plotting 
t=X(:,1); 
x1=X(:,2); 
s1=S(:,2); 
y1=Y(:,2); 
v1=V(:,2); 
z1=Z(:,2); 
p1=P(:,2); 
k1=K(:,2); 
plot (t,(x1+s1+y1)/N0,'r') 
%second pass for second plot on simulation with 5*omega_k from figure 6 
%days for simulation to run 
days=4380; 
% defining variables 
alpha=5*10^9; 
mu=.02; 
k0=1*10^-12; 
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mu_Y=.6; 
delta_Y=.6; 
beta=150; 
mu_V=6; 
delta_V=5; 
theta=10^-6; 
rho=.1; 
omega_P=1.4*10^-14; 
omega_K=5*1.1*10^-15; 
Zmax=1; 
Pmax=1; 
Kmax=20; 
a=10^3; 
b=.2; 
c=2; 
d=10^-2; 
% initial values of intergration 
N0=2.5*10^11; 
X0=.7*2.5*10^11; 
S0=.3*2.5*10^11; 
Y0=0; 
V0=1; 
Z0=10^-6; 
P0=.3; 
K0=1; 
% simulation 
sim('untitled_P_01_08') 
% plotting 
t=X(:,1); 
x1=X(:,2); 
s1=S(:,2); 
y1=Y(:,2); 
v1=V(:,2); 
z1=Z(:,2); 
p1=P(:,2); 
k1=K(:,2); 
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plot (t,(x1+s1+y1)/N0,'c') 
%third pass for second plot on simulation with 1/5*omega_k from figure 6 
%days for simulation to run 
days=4380; 
% defining variables 
alpha=5*10^9; 
mu=.02; 
k0=1*10^-12; 
mu_Y=.6; 
delta_Y=.6; 
beta=150; 
mu_V=6; 
delta_V=5; 
theta=10^-6; 
rho=.1; 
omega_P=1.4*10^-14; 
omega_K=1/5*1.1*10^-15; 
Zmax=1; 
Pmax=1; 
Kmax=20; 
a=10^3; 
b=.2; 
c=2; 
d=10^-2; 
% initial values of intergration 
N0=2.5*10^11; 
X0=.7*2.5*10^11; 
S0=.3*2.5*10^11; 
Y0=0; 
V0=1; 
Z0=10^-6; 
P0=.3; 
K0=1; 
% simulation 
sim('untitled_P_01_08'); 
% plotting 
t=X(:,1); 
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x1=X(:,2); 
s1=S(:,2); 
y1=Y(:,2); 
v1=V(:,2); 
z1=Z(:,2); 
p1=P(:,2); 
k1=K(:,2); 
plot (t,(x1+s1+y1)/N0,'m') 
% %first pass for plot of Omega_P in Figure 7 
% %days for simulation to run 
% days=4380; 
%  
% % defining variables 
%  
% alpha=5*10^9; 
% mu=.02; 
% k0=1*10^-12; 
% mu_Y=.6; 
% delta_Y=.6; 
% beta=150; 
% mu_V=6; 
% delta_V=5; 
% theta=10^-6; 
% rho=.1; 
% omega_P=1.4*10^-14; 
% omega_K=1.1*10^-15; 
% Zmax=1; 
% Pmax=1; 
% Kmax=20; 
% a=10^3; 
% b=.2; 
% c=2; 
% d=10^-2; 
%  
% % initial values of intergration 
% N0=2.5*10^11; 
% X0=.7*2.5*10^11; 
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% S0=.3*2.5*10^11; 
% Y0=0; 
% V0=1; 
% Z0=10^-6; 
% P0=.3; 
% K0=1; 
% % simulation 
% sim('untitled_P_01_08') 
% % plotting 
% t=X(:,1); 
% x1=X(:,2); 
% s1=S(:,2); 
% y1=Y(:,2); 
% v1=V(:,2); 
% z1=Z(:,2); 
% p1=P(:,2); 
% k1=K(:,2); 
% plot (t,(x1+s1+y1)/N0,'k--') 
%second pass for plot of 2*Omega_P in Figure 7 
%days for simulation to run 
days=4380; 
% defining variables 
alpha=5*10^9; 
mu=.02; 
k0=1*10^-12; 
mu_Y=.6; 
delta_Y=.6; 
beta=150; 
mu_V=6; 
delta_V=5; 
theta=10^-6; 
rho=.1; 
omega_P=2*1.4*10^-14; 
omega_K=1.1*10^-15; 
Zmax=1; 
Pmax=1; 
Kmax=20; 
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a=10^3; 
b=.2; 
c=2; 
d=10^-2; 
% initial values of intergration 
N0=2.5*10^11; 
X0=.7*2.5*10^11; 
S0=.3*2.5*10^11; 
Y0=0; 
V0=1; 
Z0=10^-6; 
P0=.3; 
K0=1; 
% simulation 
sim('untitled_P_01_08') 
% plotting 
t=X(:,1); 
x1=X(:,2); 
s1=S(:,2); 
y1=Y(:,2); 
v1=V(:,2); 
z1=Z(:,2); 
p1=P(:,2); 
k1=K(:,2); 
plot (t,(x1+s1+y1)/N0,'y') 
%third pass for plot of 1/2*Omega_P in Figure 7 
%days for simulation to run 
days=4380; 
% defining variables 
alpha=5*10^9; 
mu=.02; 
k0=1*10^-12; 
mu_Y=.6; 
delta_Y=.6; 
beta=150; 
mu_V=6; 
delta_V=5; 
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theta=10^-6; 
rho=.1; 
omega_P=.5*1.4*10^-14; 
omega_K=1.1*10^-15; 
Zmax=1; 
Pmax=1; 
Kmax=20; 
a=10^3; 
b=.2; 
c=2; 
d=10^-2; 
% initial values of intergration 
N0=2.5*10^11; 
X0=.7*2.5*10^11; 
S0=.3*2.5*10^11; 
Y0=0; 
V0=1; 
Z0=10^-6; 
P0=.3; 
K0=1; 
% simulation 
sim('untitled_P_01_08') 
% plotting 
t=X(:,1); 
x1=X(:,2); 
s1=S(:,2); 
y1=Y(:,2); 
v1=V(:,2); 
z1=Z(:,2); 
p1=P(:,2); 
k1=K(:,2); 
plot (t,(x1+s1+y1)/N0,'k') 
legend('P=.1','P=.8','Omega_K_&_P','5*Omega_K','1/5*Omega_K','2*Omega_P','.5*
Omega_P') 
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